Vertero Therapeutics, Inc.
Founded 2016 · 2 known investors
Vertero is a biotech company developing oral therapeutics that target peripheral drivers of neurodegenerative diseases such as Parkinson's. Its lead candidate, VT-5006, targets a validated target in the gut linked to the protein aggregation and inflammation associated with Parkinson's disease.
BiotechHealthtech
Investors · 2
Frequently asked questions
- What does Vertero Therapeutics, Inc. do?
- Vertero is a biotech company developing oral therapeutics that target peripheral drivers of neurodegenerative diseases such as Parkinson's. Its lead candidate, VT-5006, targets a validated target in the gut linked to the protein aggregation and inflammation associated with Parkinson's disease.
- Who are Vertero Therapeutics, Inc.'s investors?
- Vertero Therapeutics, Inc.'s investors include Taiho Ventures, LLC, UTokyo Innovation Platform Co. Ltd..